Cargando…

Association of genetic variants of the incretin-related genes with quantitative traits and occurrence of type 2 diabetes in Japanese

BACKGROUND: None of the high frequency variants of the incretin-related genes has been found by genome-wide association study (GWAS) for association with occurrence of type 2 diabetes in Japanese. However, low frequency and rare and/or high frequency variants affecting glucose metabolic traits remai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enya, Mayumi, Horikawa, Yukio, Iizuka, Katsumi, Takeda, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121356/ https://www.ncbi.nlm.nih.gov/pubmed/27896108 http://dx.doi.org/10.1016/j.ymgmr.2014.07.009

Ejemplares similares

Synergistic effect of α‐glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment
por: Horikawa, Yukio, et al.
Publicado: (2010)

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2011)

Knowledge of diabetes and its determinants: a cross-sectional study among adults in a Japanese community
por: Oba, Shino, et al.
Publicado: (2019)

ChREBP Reciprocally Regulates Liver and Plasma Triacylglycerol Levels in Different Manners
por: Iizuka, Katsumi, et al.
Publicado: (2018)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption
por: Kato, Takehiro, et al.
Publicado: (2018)

Effect of hypertriglyceridemia in dyslipidemia‐induced impaired glucose tolerance and sex differences in dietary features associated with hypertriglyceridemia among the Japanese population: The Gifu Diabetes Study
por: Nonoyama, Yukiko, et al.
Publicado: (2020)

Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitor as an Add-on Drug to GLP-1 Receptor Agonists for Glycemic Control of a Patient with Prader–Willi Syndrome: A Case Report
por: Horikawa, Yukio, et al.
Publicado: (2018)

L-Arginine prevents cereblon-mediated ubiquitination of glucokinase and stimulates glucose-6-phosphate production in pancreatic β-cells
por: Cho, Jaeyong, et al.
Publicado: (2020)

Type 1 Diabetes Mellitus and Klinefelter Syndrome
por: Sakurai, Teruaki, et al.
Publicado: (2018)

Incretins and cardiovascular disease: to the heart of type 2 diabetes?
por: Solini, Anna, et al.
Publicado: (2023)

ChREBP Rather Than SHP Regulates Hepatic VLDL Secretion
por: Niwa, Hiroyuki, et al.
Publicado: (2018)

The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010)

Incretin response in Asian type 2 diabetes: Are Indians different?
por: Singh, Awadhesh Kumar
Publicado: (2015)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
por: Bonde, Lawrence, et al.
Publicado: (2006)

First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications
por: Yoshiji, Satoshi, et al.
Publicado: (2021)

Studies of a genetic variant in HK1 in relation to quantitative metabolic traits and to the prevalence of type 2 diabetes
por: Gjesing, Anette P, et al.
Publicado: (2011)

Incretins in the Therapy of Diabetic Kidney Disease
por: Przezak, Agnieszka, et al.
Publicado: (2021)

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes
por: Schnabel, Catherine A, et al.
Publicado: (2006)

Emerging role of insulin with incretin therapies for management of type 2 diabetes
por: Ahluwalia, Rupa, et al.
Publicado: (2011)

The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis
por: Terawaki, Yuichi, et al.
Publicado: (2013)

Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
por: Gracia‐Ramos, Abraham Edgar
Publicado: (2019)

Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
por: Boer, Geke Aline, et al.
Publicado: (2020)

New prospects for incretin‐related drugs in the treatment of type 2 diabetes
por: Kimura, Tomohiko, et al.
Publicado: (2020)

Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
por: Ahn, Chang Ho, et al.
Publicado: (2023)

Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium
por: Palmer, Nicholette D., et al.
Publicado: (2015)

TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
por: Villareal, Dennis T., et al.
Publicado: (2010)

Maturity‐onset diabetes of the young as a model for elucidating the multifactorial origin of type 2 diabetes mellitus
por: Horikawa, Yukio
Publicado: (2018)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Genetic variants in the upstream region of activin receptor IIA are associated with female fertility in Japanese Black cattle
por: Sasaki, Shinji, et al.
Publicado: (2015)

Incretin responses to oral glucose load in Japanese non-obese healthy subjects
por: Nagai, Etsuko, et al.
Publicado: (2011)

Incretin Kinetics Before and After Miglitol in Japanese Patients With Late Dumping Syndrome
por: Amagai, Mari, et al.
Publicado: (2017)

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
por: Drucker, Daniel J., et al.
Publicado: (2010)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Schwartz, Stanley, et al.
Publicado: (2010)

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
por: Khoo, Joan, et al.
Publicado: (2009)

Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
por: Nisal, Kaustubh, et al.
Publicado: (2012)

Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes
por: Tibaldi, Joseph M.
Publicado: (2014)

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nr7il2jqsr7r3k72qjmgme5dsa